Perseus Proteomics Inc.

Our Antibodies open up Future Therapy

Business01

Drug discovery

Business02

Business03

Search for antibody product information

Please enter search terms, such as the clone number, antigen name, or UniProtKB ID of the antibody of interest.

2020/04/27: PPMX-T002: Announcement of Phase I Clinical Trial Initiation in Japan on FF-21101, Radio-labeled antibody by FUJIFILM Toyama Chemical
2020/03/11: Notice of server maintenance
2018/11/15: On November 15, 2018, our popular anti-human SF-1 antibody was relaunched as Protein A-purified grade.
2018/03/30: PPMX received 1.4 billion yen from Nippon Venture Capital Co.,Ltd. and other capitals in a third party allocation of shares.
2016/01/12: Fujifilm initiates a Phase I clinical trial of the anti-cancer agent “FF-21101” (RI labeled antibody) in the United States. PPMX contributed to creating antibody based on antibody engineering technology.